This schedule also reduces the chance that magnesium supplementation will interfere with appetite suppression benefits during the day
Tirzepatide (Mounjaro) NICE recommended Mounjaro to be used as a weight loss medication by the NHS in December 2024 for people with a very high BMI and additional health conditions linked to their obesity, such as hypertension
Marsico F, Paolillo S, Gargiulo P, Bruzzese D, DellAversana S, Esposito I, Renga F, Esposito L, Marciano C, Dellegrottaglie S, Iesu I, Perrone Filardi P
Clinical studies show that tirzepatide can produce meaningful average weight reduction when used with a reduced-calorie diet and increased physical activity